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 Introduction 
 Membrane biogenesis is dependent on phospholipid synthesis, 
specifi cally phosphatidylcholine (PtdCho), the most abundant 
phospholipid component that forms the bilayer barrier structure 
in eukaryotic cells. Doubling of the membrane phospholipid 
during cell cycle progression is regulated in part by the phos-
phocholine cytidylyltransferase (CCT;  Jackowski, 1994, 1996 ), 
a key enzyme in PtdCho synthesis ( Jackowski and Fagone, 
2005 ). Also, biochemical activation of CCT mediates expansion 
of the ER membrane in B lymphocytes that are activated by 
lipopolysaccharide (LPS;  Fagone et al., 2007 ). Inactivation of 
CCT either genetically or pharmacologically in immortalized 
cells leads to cell death ( Lykidis and Jackowski, 2001 ;  Cui and 
Houweling, 2002 ). Genetic deletion in mice of the ubiquitous 
CCT  isoform is lethal in embryogenesis before the blastocyst 
stage ( Wang et al., 2005 ). These results and the fact that the 
CCT  isoform is expressed at levels 10- to 30-fold higher than 
the   isoforms ( Jackowski et al., 2004 ) suggest that CCT  activ-
ity is required to support membrane biogenesis. However, tissue-
specifi c deletion of CCT  in mice does not severely restrict 
the proliferation or development of mouse macrophages ( Zhang 
et al., 2000 ), hepatocytes ( Jacobs et al., 2004 ), or lung epithelial 
cells ( Tian et al., 2007 ), which demonstrates that either ex-
pression of the CCT  2 or CCT  3 isoforms in mice ( Karim 
et al., 2003 ) is suffi cient for development and differentiation, 
and/or that circulating lipoproteins supply substantial amounts 
of PtdCho to primary cells and tissues ( Gunter et al., 2007 ). 
However, the loss of CCT  expression does alter the differenti-
ated function of these cell types. CCT  -defi cient macrophages 
have increased susceptibility to cell death by apoptosis after 
challenge with cholesterol ( Zhang et al., 2000 ;  Devries-Seimon 
et al., 2005 ). Defi cient hepatocytes are larger, and secretion of 
high-density lipoprotein and very low-density lipoprotein from 
the liver is impaired ( Jacobs et al., 2004 ). Conditional deletion 
Choline cytidylyltransferase (CCT) is the rate-limiting enzyme in the phosphatidylcholine biosynthetic pathway. Here, we demonstrate that CCT  -mediated 
phosphatidylcholine synthesis is required to maintain 
 normal Golgi structure and function as well as cytokine 
secretion from the Golgi complex. CCT  is localized to the 
trans-Golgi region and its expression is increased in lipo-
polysaccharide (LPS)-stimulated wild-type macrophages. 
Although LPS triggers transient reorganization of Golgi 
morphology in wild-type macrophages, similar structural 
alterations persist in CCT  -deﬁ cient cells. Pro – tumor necrosis 
factor   and interleukin-6 remain lodged in the secretory 
compartment of CCT  -deﬁ cient macrophages after LPS 
stimulation. However, the lysosomal-mediated secretion 
pathways for interleukin-1  secretion and constitutive 
apolipoprotein E secretion are unaltered. Exogenous lyso-
phosphatidylcholine restores LPS-stimulated secretion from 
CCT  -deﬁ cient cells, and elevated diacylglycerol levels alone 
do not impede secretion of pro – tumor necrosis factor   
or interleukin-6. These results identify CCT  as a key 
component in membrane biogenesis during LPS-stimulated 
cytokine secretion from the Golgi complex.
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 In proliferating cells, the ER is a major site of PtdCho syn-
thesis ( Henneberry et al., 2002 ;  Fagone et al., 2007 ;  Sriburi 
et al., 2007 ), and PtdCho is then mobilized to the Golgi compart-
ment ( Altan-Bonnet et al., 2004, 2006 ). DAG production is initi-
ated by the breakdown of PtdCho by phospholipase D followed 
by a PtdOH phosphatase (P ’ tse), and this process promotes se-
cretion through the Golgi apparatus ( Kearns et al., 1997 ;  Litvak 
et al., 2005 ;  Lev, 2006 ). Maintaining the supply of DAG is criti-
cal to secretion in both yeast and mammalian cells, and the in-
hibition of PtdCho synthesis increases DAG ( Kearns et al., 1997 ; 
 Litvak et al., 2005 ). DAG is reincorporated into PtdCho by cho-
line phosphotransferase (CPT) activity located at the Golgi ap-
paratus ( Henneberry et al., 2002 ;  Gilchrist et al., 2006 ), but the 
limiting substrate for this reaction is cytidine diphosphocholine 
(CDP – Cho) produced by CCT ( Jackowski and Fagone, 2005 ). 
In this study, we fi nd that genetic inactivation of the major CCT 
isoform in murine macrophages resulted in reduced PtdCho syn-
thesis and increased DAG levels, coupled with impaired secre-
tion of cytokines from the Golgi apparatus of stimulated cells. 
The experiments illustrate that PtdCho biosynthesis is critical for 
vesicular traffi c from the Golgi apparatus and that aberrantly 
high DAG levels do not impede vesicular transport. 
 Results 
 Mice with CCT  -null macrophages were derived as described 
previously ( Zhang et al., 2000 ). In brief, mice carrying a fl oxed 
 Pcyt1a gene were crossed with mice carrying a  Cre recombinase 
driven by the macrophage-specifi c LysM promoter. Two fl ox sites 
fl anked a 12.5-kb fragment of the  Pcyt1a gene containing exons 
5 – 9 ( Karim et al., 2003 ) and the intervening introns. Deletion 
of the region between the fl ox sites resulted in expression of a 
of CCT  in lung epithelia results in insuffi cient synthesis and 
secretion of dipalmitoyl-PtdCho, the major surfactant phospho-
lipid ( Tian et al., 2007 ). These data obtained by inactivation 
of CCT  in selected primary cells argue for specifi c roles for 
PtdCho synthesis in supporting the function rather than the for-
mation of differentiated cells. 
 Macrophages are multitalented cells in natural host 
defense that are activated to protect against a wide variety of 
 invading microorganisms. The cells also have extensive bio-
synthetic capabilities that result in the secretion of complement 
components, cytokines, prostaglandins, and numerous other 
biologically active factors that modulate the activities of other 
lymphoreticular cells. Many macrophage functions, including 
phagocytosis and secretion, involve membrane reconfi guration 
and movement, and are often accompanied by remodeling of the 
membrane lipids. For example, the phospholipase D1 (PLD1; 
 Iyer et al., 2004 ;  Corrotte et al., 2006 ) converts the PtdCho into 
phosphatidic acid (PtdOH), cytoplasmic phospholipase A 2 is re-
cruited to the phagosome ( Girotti et al., 2004 ) to release arachi-
donic acid, an eicosanoid precursor, and the phosphorylated 
inositol phospholipids undergo localized changes during phago-
some formation ( Lindmo and Stenmark, 2006 ;  Yeung et al., 
2006 ). The generation of polyphosphoinositides, DAG, and 
PtdOH regulate secretion events ( Roth, 1999 ;  Huijbregts et al., 
2000 ;  Freyberg et al., 2003 ;  Wenk and De, 2004 ;  Munro, 2005 ; 
 Lev, 2006 ) by recruiting cytoplasmic proteins to the Golgi appa-
ratus or secretory vesicles to modify the membrane or couple 
with effector molecules. These localized changes in lipid com-
position signal traffi cking proteins and also infl uence membrane 
organization and properties, thus promoting membrane fi ssion 
or fusion ( Weigert et al., 1999 ;  Shemesh et al., 2003 ;  Corda 
et al., 2006 ;  Carrasco and Merida, 2007 ). 
 Figure 1.  Reduced PtdCho synthesis in CCT  -
deﬁ cient macrophages. (A) Wild-type (WT; 
 n = 12) or CCT  -deﬁ cient (KO;  n = 12) macro-
phages were labeled for 6 h with 1  μ Ci/ml 
[ 3 H]choline, and incorporation into PtdCho 
was normalized to cellular protein. (B) Relative 
transcript levels for CCT  , CCT  2, CCT  3, or 
PEMT were determined by real-time qRT-PCR 
in wild-type ( n = 3) or CCT  -deﬁ cient ( n = 3) 
macrophages. (C) CCT enzyme activity in wild-
type (  ;  n = 4) or CCT  -deﬁ cient (  ;  n = 4) 
macrophage lysates was determined in vitro as 
a function of protein concentration. (D) Protein 
expression levels of CCT  (42 kD) and CCT  3 
(39 kD) were determined in wild-type and 
CCT  -deﬁ cient macrophage lysates (50  μ g) by 
immunoblotting with isoform-speciﬁ c antibodies. 
Immunoblots are representative of macrophages 
from two mice of each genotype. Cells (HEK293T) 
transfected with expression plasmids encoding 
CCT  or CCT  3 were lysed, and 5  μ g of pro-
tein was loaded as a positive control. Multiple 
immunopositive bands in a lane correspond to 
different phosphorylation states of the CCT 
protein ( Jackowski, 1994 ;  Lykidis et al., 1998 ). 
Error bars indicate mean  ± SE. *, P  < 0.05; 
**, P  < 0.01. 
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migration and chemotaxis of the macrophages in response to 
the attractant formyl-methionylleucylphenylalanine (fMLP) was 
determined in modifi ed Boyden chambers. The numbers of cells 
that crossed a membrane into an adjacent chamber containing 
medium alone or medium plus 10 nM fMLP were determined by 
staining with Calcein AM, and the data were normalized to the 
starting cell number. The assay was linear for at least 4 h and 
both the knockout and wild-type cell populations exhibited 
similar rates of random migration and chemotaxis ( Fig. 2 B ). 
Cytokine production by macrophages in response to  E. coli LPS 
truncated CCT  protein that lacked the catalytic and regulatory 
domains located at the carboxy terminus. Mice that were homozy-
gous for the fl oxed gene and heterozygous for the LysMCre gene 
were mated, and the pups were genotyped and used to obtain ei-
ther CCT  knockout or littermate wild-type control macrophages. 
Peritoneal macrophages were elicited, and the CCT  -defi cient 
macrophage population was confi rmed to have reduced rates of de 
novo PtdCho synthesis as measured by [ 3 H]choline incorporation 
into the lipid fraction of adherent cells ( Fig. 1 A ). The deletion in 
this macrophage model was not completely penetrant ( Zhang 
et al., 2000 ). Analysis of the CCT  transcript level in CCT  -
 defi cient macrophages by quantitative RT-PCR (qRT-PCR) re-
vealed that the transcript level was signifi cantly reduced to 30% 
of the wild-type level ( Fig. 1 B ). The CCT  -null cells were  ≥ 95% 
macrophages as determined microscopically after staining with 
macrophage-specifi c anti – mouse CD11b. Cells were also stained 
for expression of CCT  protein, and 20 – 30% of the macrophages 
isolated from individual knockout mice ( n = 4) remained positive 
for expression, which confi rms that the action of the Cre recombi-
nase was not 100% penetrant. Thus, the residual PtdCho synthesis 
measured by metabolic radiolabeling in the CCT  -null popula-
tions was due not only to expression of the alternate isoform, 
CCT  3 ( Fig. 1 B ), but also to the presence of cells that did not 
delete the CCT  gene. The qRT-PCR revealed that the CCT  2 
isoform was not expressed in macrophages, and that CCT  3 ex-
pression was increased in the knockouts. CCT  3 is equivalent to 
CCT  in its primary biochemical function, and expression of its 
activity can compensate for loss of CCT  to support bulk mem-
brane synthesis in cultured cells ( Karim et al., 2003 ). It was previ-
ously found that CCT  2 expression increased in the CCT  -defi cient 
cells ( Zhang et al., 2000 ), but at the time, CCT  3 had not been 
discovered, and both isoforms share the common epitope that was 
signaled in the previous immunoblots ( Karim et al., 2003 ). Total 
CCT activity was signifi cantly lower in cell lysates prepared from 
CCT  -null macrophages compared with wild-type populations 
( Fig. 1 C ), and these data agreed with the previously published 
study ( Zhang et al., 2000 ). The decrease in CCT  and the increase 
in CCT  3 protein assessed by immunoblotting with isoform-
 specifi c antibodies refl ected the changes in mRNA levels ( Fig. 1 D ). 
Macrophages were isolated from two knockout and two wild-type 
mice and pooled according to genotype, then immunoblots were 
prepared from six replicates of each genotype. The level of CCT  
protein in the knockout population was 0.36  ± 0.08 compared with 
the wild-type population (level set at 1.00). The reduction in CCT  
transcripts correlated with the protein level determined by 
immunoblots and with the number of macrophages devoid of 
CCT  expression as determined by microscopy of immunostained 
cell populations. These data confi rm the loss of CCT  expression 
in the majority of cells and also provide the fi rst example of 
CCT  3 regulation as an adaptive response to PtdCho defi ciency. 
 Several macrophage functions were assessed to determine 
if they were compromised by reduced PtdCho synthesis. Phago-
cytosis was evaluated by quantifying the uptake of fl uorescein-
labeled  Escherichia coli , and the values were normalized to cell 
number by counterstaining and measuring DAPI fl uorescence. 
The uptake of the bacteria was linear up to 2 h and was the same 
in both wild-type and CCT  -defi cient cells ( Fig. 2 A ). Random 
 Figure 2.  Functional comparison of wild-type and CCT  -deﬁ cient macro-
phages. (A) Phagocytosis of ﬂ uorescein-labeled  E. coli was quantiﬁ ed after 
2 h of incubation and then normalized to the cell number by staining with 
DAPI as described in Materials and methods ( n = 8). (B) Chemotaxis was 
measured by migration of wild-type (WT;  n = 8) or CCT  -deﬁ cient (KO; 
 n = 16) macrophages in modiﬁ ed Boyden chambers after 4 h of incubation 
with either LCM or LCM plus  n- fMLP. The numbers of cells in the target 
chambers were determined by staining with Calcein AM, quantiﬁ cation of 
the ﬂ uorescent signal, and comparison with a calibration curve of increas-
ing cell number. (C) Cytokine and PGE 2 secretion from wild-type (white; 
 n = 8) and CCT  -deﬁ cient (black;  n = 8) macrophages 18 h after LPS 
stimulation was measured with the Luminex assay (BioRad Laboratories) 
or by individual ELISA assays and normalized to protein content in each 
sample. The mean values for cytokines in the medium from WT cells were: 
TNF  , 319.3 pg/ μ g cell protein; IL-6, 266.2 pg/ μ g cell protein; IL-1  , 
15.3 pg/ μ g cell protein; and PGE 2 , 5.46 pg/ μ g cell protein. Error bars 
indicate mean  ± SE. *, P  < 0.05; **, P  < 0.01. 
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from the wild-type cells by 24 h. TNF  processing is con-
current with its movement from the Golgi to the cell surface 
and mediated by a metalloprotease called TNF  -converting en-
zyme (TACE;  Gearing et al., 1994, 1995 ). A TACE inhibitor, 
N -( d , l -[2-(hydroxyaminocarbonyl)methyl]-4-methylpentanoyl)- l -
3-(2  naphthyl)-alanyl- l -alanine, 2-aminoethylamide (TAPI;  Crowe 
et al., 1995 ), was added to wild-type macrophages after LPS 
 addition to inhibit TNF  processing and confi rm the identifi ca-
tion of the pro-TNF  on the blots ( Fig. 3 ). TAPI abolished TNF  
release to the medium, but TAPI did not inhibit IL-6 secretion 
from wild-type cells (Fig. S2). The data demonstrated that LPS 
signaling and cytokine synthesis were intact in the CCT  -
defi cient macrophages. Because IL-6 secretion was not com-
promised, the inhibition of TACE activity by PtdCho defi ciency 
was ruled out as a mechanism for the TNF  secretion defect. 
Constitutive secretion of apolipoprotein E (ApoE) was not de-
pendent on LPS stimulation and was not impaired in the CCT  -
null cells ( Fig. 3 D ). The synthesis of ApoE is repressed at the 
transcript level after LPS stimulation ( Gafencu et al., 2007 ), and, 
thus, the amount released to the medium was reduced in both 
wild-type and knockout cells at later times after LPS stimula-
tion ( Figs. 3 D and S3 A). Imaging of cellular TNF  and ApoE 
was measured by sampling the culture medium 18 h after addition 
of the ligand. Secretion of TNF  , and interleukin-6 (IL-6) was 
reduced in the CCT  -defi cient population, but the secretion of 
 interleukin-1  (IL-1  ) was comparable to that in wild-type cells 
( Fig. 2 C ). Both TNF  and IL-6 are delivered to the medium by 
vesicle-mediated secretion from the Golgi apparatus. IL-1  is 
transported by ATP-dependent secretion of specialized lysosomes 
that bypass the Golgi compartment ( Andrei et al., 2004 ). The re-
lease of prostaglandin E 2 (PGE 2 ) was also normal in the CCT  -
null cells ( Fig. 2 C ). Altogether, these data indicated that LPS 
signaling was intact and that secretion of cytokines from the Golgi 
apparatus was impaired in the CCT  -defi cient macrophages. 
 A time course revealed reduced release of both TNF  and 
IL-6 from the knockout cells into the medium ( Fig. 3, A and C ). 
Reduced cytokine secretion was refl ected in reduced total 
 production of the cytokines (Fig. S1, available at http://www
.jcb.org/cgi/content/full/jcb.200706152/DC1). Immunoblotting 
of cell lysates at 12 and 24 h after stimulation showed that TNF  
accumulated in the CCT  -defi cient macrophages as both the pre-
cursor and the mature form ( Fig. 3 B ). In contrast, the membrane-
bound precursor form of TNF  (pro-TNF  ) was quantitatively 
processed to the soluble mature form and completely released 
 Figure 3.  Secretion and processing of TNF  . (A) TNF  in the culture medium from wild-type (  ;  n = 5) or CCT  -deﬁ cient (  ;  n = 10) macrophages was 
measured at indicated times after LPS stimulation. The anti-TNF  antibody used in the ELISA recognized both the pro-TNF  and mature TNF  . (B) Synthesis 
and processing of TNF  was evaluated by immunoblotting cell lysates from wild-type (WT) or CCT  -deﬁ cient (KO) macrophages. Cells were treated with 
LPS for either 12 or 24 h, or with an inhibitor of TACE, TAPI, which was added to selected cultures to conﬁ rm the identiﬁ cation of the unprocessed pro-TNF  . 
Puriﬁ ed recombinant mouse TNF  (Leinco Technologies, Inc.) was a positive control (lane 1), and anti-GAPDH mAb (Ambion) was used to conﬁ rm equal 
protein loading (50  μ g) in each lane. The data are representative of three independent experiments. (C) IL-6 in the culture medium from the same macro-
phages used in A. (D) Apo E secretion was evaluated by immunoblotting the culture medium from wild-type or CCT  -deﬁ cient macrophages incubated for 
18 h with and without LPS. Equal volumes of the culture medium were loaded onto the gel, and the immunoblot densities were quantiﬁ ed. The data are the 
mean  ± SE from two independent determinations using macrophages from a total of four mice of each genotype. 
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not artifacts of manipulation of the cells or the in vitro system. 
The numbers of circulating monocytes, peritoneal macrophages, 
and bone marrow macrophages in the knockout animals were 
the same or slightly greater than those from the wild-type mice 
(Fig. S4, available at http://www.jcb.org/cgi/content/full/jcb
.200706152/DC1). We subjected both wild-type and knockout 
mice to infection with an intranasal dose (10 7 colony-forming 
units) of luminescent  Streptococcus pneumoniae strain T4X and 
followed the course of the infection in fi ve to six individual litter-
mate mice of each genotype ( Fig. 5 A ). Wild-type mice developed 
mild pneumonia and between 10 and 50% succumbed in three 
 independent experiments. In contrast, mice with CCT  -defi cient 
macrophages developed more serious diffuse pneumonia, with 
higher bacterial counts, and the disease quickly progressed to sep-
sis ( Fig. 5 A ), with a mean 70% mortality rate ( Fig. 5 B ). In lungs 
of knockout animals, there were extensive areas of interstitial 
pneumonia with consolidation, necrosis, and marked fi brino-
purulent pleuritis ( Fig. 5 C , top). The infl ammatory infi ltrate in 
the pneumonic areas was composed of viable and degenerate neu-
trophils, macrophages, and perivascular cuffs of lymphocytes 
and plasma cells. In lungs of wild-type mice, there were patchy 
mild interstitial infl ammatory infi ltrates composed primarily of 
in the same cells indicated that these secretory products were 
located in different compartments (Fig. S3 B), which supports 
the view that ApoE exited from the Golgi compartment via dif-
ferent vesicles. New PtdCho biosynthesis was not required for 
secretion of ApoE but was necessary for the release of TNF  
and IL-6 after LPS stimulation. 
 The process of cytokine synthesis and secretion in the 
macrophages was investigated using immunocytochemistry. 
Wild-type and knockout cells were treated with LPS for 6 and 
18 h before fi xation and then stained with anti-TNF  or anti –
 IL-6 antibodies ( Fig. 4, A and B ). The images confi rmed that the 
CCT  -defi cient cells were able to synthesize TNF  and IL-6. 
Intracellular TNF  and IL-6 were detected at 6 h, whereas wild-
type cells were negative for these cytokines by 18 h after LPS 
stimulation. These results correlated with cellular cytokine syn-
thesis and secretion to the medium. However, both cytokines 
were still retained within the CCT  -defi cient cells up to 48 h 
after LPS stimulation. 
 The results described thus far were obtained using thio-
glycolate-elicited macrophages that were isolated by peritoneal 
lavage and cultured in vitro. The physiological relevance of the 
phenotype was tested in vivo to ensure that the fi ndings were 
 Figure 4.  TNF  and IL-6 accumulation in the CCT  -
 deﬁ cient macrophages. (A) Wild-type (WT) or CCT  -
deﬁ cient (KO) macrophages were treated with LPS, ﬁ xed, 
and stained with anti-TNF  antibody (green) at 0, 6, 
or 18 h. (B) Wild-type or CCT  -deﬁ cient macrophages 
were treated with LPS and stained with anti – IL-6 antibody 
(green) at 0, 6, or 18 h. Cell nuclei in A and B were 
counterstained with DAPI (blue). At least 100 cells were 
visualized in each of two independent experiments. Bar, 
10  μ m. 
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macrophages to accumulate TNF  and impaired cytokine 
secretion in vivo. 
 The reorganization of the Golgi apparatus after LPS stim-
ulation was compared between wild-type and CCT  -defi cient 
macrophages using an antibody that recognizes the ER – Golgi 
intermediate compartment 53-kD protein (ERGIC-53), a pro-
tein specifi cally localized in the ER and cis-Golgi compartment 
( Litvak et al., 2005 ). The images indicated only limited re-
arrangement of the marker protein after LPS stimulation and 
a similar distribution in both wild-type and knockout cells 
( Fig. 6 ). Next, the trans-Golgi compartment was imaged with an 
antibody that recognizes the K58 marker protein ( Bloom and 
Brashear, 1989 ). K58 was located proximal to the cell nucleus 
and surrounded 30 – 50% of the nucleus before LPS stimulation. 
In wild-type cells, the K58 protein coalesced into a focused 
structure at a distinct perinuclear site by 6 h and then returned to 
the more diffuse distribution characteristic of unstimulated cells 
at 18 h after LPS activation ( Fig. 6 ). In the CCT  -defi cient 
neutrophils with fewer macrophages and perivascular and peri-
bronchiolar infi ltrates of lymphocytes and plasma cells. A Gram ’ s 
stain to detect bacteria in the lung tissue revealed abundant cocci 
in the knockout animals ( Fig. 5 C , bottom), particularly embed-
ded in the layers of fi brin along the pleural surface (arrows), 
whereas Gram-positive cocci were rarely observed in the wild-
type lungs. The numbers of macrophages in the knockout model 
were equivalent to the numbers in wild-type animals (Fig. S4, 
A – C), and the knockout macrophages at the site of infection ac-
cumulated and retained TNF  , in contrast to the wild-type macro-
phages ( Fig. 5 D ). The macrophages that infi ltrated the lungs 
48 h after infection were identifi ed in cryosections with an anti –
 MAC-1 antibody and counterstained with an anti-TNF  antibody. 
The wild-type macrophages were devoid of the cytokine by this 
time, but the majority of knockout cells still retained a strong 
signal, which indicates that the cytokine had not yet been 
released into the extracellular space ( Fig. 5 D ). These data 
supported the hypothesis that CCT  defi ciency caused the 
 Figure 5.  Aberrant cytokine release from CCT  -deﬁ cient macrophages after bacterial infection. (A) Distribution of  S. pneumoniae LUX at 3 d after intra-
nasal challenge. Bacterial numbers are proportional to the color bar on the right. Note the small focus of bacteria in lungs of the wild-type (WT) mouse 
versus systemic bacteremia in the knockout (KO) mouse. Images are representative of the mice from three independent experiments. (B) Survival of mice 
with wild-type (  ;  n = 16) or CCT  -deﬁ cient (  ;  n = 16) macrophages after bacterial challenge. The results were compiled from three independent experi-
ments. Error bars indicate mean  ± SE. (C) Lung pathology at 3 d after infection. Hematoxylin and eosin staining (top) illustrates more severe pneumonia 
and Gram ’ s staining (bottom) illustrates increased bacterial proliferation (arrows) with CCT  -null macrophages. Bars, 30  μ m. (D) 10- μ m-thick frozen sections 
obtained from mouse lung tissue. Inﬁ ltrating macrophages 48 h after infection were identiﬁ ed by positive MAC-1 staining (red) and TNF  staining (green), 
and cells were counterstained with DAPI (blue). MAC-1 – positive signals, 11 – 15 per 40 × ﬁ eld, from alveolar and interstitial macrophages were examined 
using three slides from each infected lung in three individual mice of each genotype. In lungs from animals with wild-type macrophages, a mean of 18% 
MAC-1 – positive cells were TNF  positive, and with CCT  -null macrophages, a mean of 82% MAC-1 – positive cells were TNF  positive. Cell nuclei are 
indicated as DAPI-positive (blue). 
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ganelle by a PLD, which is activated by secretory stimuli. PtdOH 
is in turn rapidly converted to DAG by a PtdOH P ’ tse. PtdCho is 
also the metabolic precursor to sphingomyelin (SM), a lipid that 
is synthesized in the Golgi compartment and then transported to 
the cell surface. Measurement of the amount before and 18 h af-
ter LPS stimulation revealed that the PtdCho was signifi cantly 
reduced in the CCT  -defi cient cells after LPS, in contrast to the 
wild-type cells, where the PtdCho level was maintained after 
stimulation ( Fig. 7 A ). In contrast, the amount of total protein 
per cell was the same in wild-type and knockout cells both 
before and after LPS (Fig. S4 F). Phosphatidylethanolamine 
(PtdEtn), the second most abundant phospholipid in intracellular 
membranes, did not change signifi cantly in the knockout cells 
after LPS stimulation (Fig. S5 A, available at http://www.jcb
.org/cgi/content/full/jcb.200706152/DC1). The DAG levels in 
CCT  -defi cient cells increased signifi cantly but remained the 
same in wild-type after LPS stimulation ( Fig. 7 B ). SM was re-
duced to the same apparent level with no statistical difference 
between the wild-type and knockout cells ( Fig. 7 C ). These data 
cells, the K58 marker behaved similarly to wild-type cells, ex-
cept that the K58 protein was still intensely focused in a single 
region adjacent to the nucleus by 18 h after LPS stimulation. 
 Interestingly, the CCT  protein in the wild-type, stimulated pri-
mary macrophages was associated with the Golgi compartment 
( Fig. 6 ). The CCT  signal converged by 6 h after LPS treatment 
and then redistributed to the more diffuse distribution sur-
rounding up to 50% of the nucleus, similar to the K58 marker. 
The CCT  protein was not visualized in   80% of the knockout 
macrophage population, and cells that expressed CCT  did not 
retain TNF  18 h after LPS (Fig. S4 E). The CCT  proteins did 
not redistribute after LPS treatment (Fig. S4 D). These data in-
dicated that the CCT  protein in primary macrophages local-
ized to the trans-Golgi region and that this compartment was the 
site of the Golgi dysfunction in the cytokine secretion pathway 
of CCT  -defi cient cells. 
 The biochemical defect underlying the phenotype in the 
knockout cells could be caused by an imbalance in several dif-
ferent lipids. PtdCho is metabolized to PtdOH in the Golgi or-
 Figure 6.  Distributions of Golgi markers in 
LPS-treated macrophages. Wild-type (WT) and 
knockout (KO) peritoneal macrophages were 
treated with LPS at 10 ng/ml for 0, 6, and 
18 h. After immediate ﬁ xation in 4% para-
formaldehyde, cells were permeabilized and 
stained with antibodies against CCT  (green), 
the trans-Golgi marker K58 (green), or the cis-
Golgi marker ERGIC-53 (green). Cell nuclei 
were counterstained with DAPI (blue). Each 
micrograph shown in the ﬁ gure is representative 
of macrophages from at least four independent 
mice. Bar, 15  μ m. 
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.jcb.org/cgi/content/full/jcb.200706152/DC1;  Shell et al., 2005 ). 
We confi rmed the data using real-time qRT-PCR on total RNA 
extracted from wild-type macrophages before and 18 h after 
LPS stimulation, and found a statistically signifi cant increase 
in the expression of these genes (Fig. S5 E). This information 
indicated the isoforms of each enzyme that worked together 
with the CCT  to control phospholipid metabolism during LPS-
stimulated cytokine secretion. Taken together, the data support 
the existence of a cycle of PtdCho degradation and resynthesis 
that accompanies cytokine secretory vesicle formation and bud-
ding from the Golgi complex ( Fig. 8 ). 
 A pharmacological approach was used to test several as-
pects of this hypothesis. Et-18-OCH 3 (edelfosine), an inhibitor of 
CCT ( Boggs et al., 1995a ), dramatically reduced TNF  secretion 
in cells of both genotypes ( Fig. 9 A ). Incubation with lysophos-
phatidylcholine (lysoPC), which is rapidly converted to PtdCho 
( Baburina and Jackowski, 1999 ), bypassed the CCT  genetic 
defect ( Esko et al., 1982 ;  Boggs et al., 1995b ;  Baburina and 
Jackowski, 1998 ) and partially restored TNF  secretion from 
CCT  -defi cient cells ( Fig. 9 A ). The LysoPC pathway would re-
plenish PtdCho but would not remove DAG. In fact, measure-
ment of the DAG level in lysoPC-treated knockout cells revealed 
that the DAG level increased (Fig. S5 F). This result was probably 
caused by inhibition of CCT  3 by lysoPC, which has been shown 
to interfere with the membrane association and activation of 
the enzyme ( Boggs et al., 1995a ;  Attard et al., 2000 ). Treatment 
of cells with either 1-butanol to inhibit phospholipase D activity, 
or propranolol to inhibit PtdOH P ’ tse activity, also inhibited 
TNF  secretion ( Fig. 9 B ). These results support the involvement 
of the phospholipase D pathway in secretion. However, fumoni-
sin B1, an inhibitor of ceramide and SM synthesis, had no effect. 
indicated a biochemical imbalance in the PtdCho and DAG but 
normal SM metabolism in the CCT  -defi cient cells. To confi rm 
that SM synthesis was unaffected in the knockout cells, macro-
phages were radiolabeled with [ 3 H]choline for 6 h with or with-
out LPS. The data showed that SM synthesis did not change 
after LPS treatment of wild-type cells and that SM synthesis 
in the knockouts was the same as the wild type (Fig. S5 B). 
Meanwhile, data from the same experiments demonstrated 
that the rate of PtdCho synthesis was reduced in the CCT  -null 
macrophages both in the unstimulated cells and after LPS 
addition. Thus, the amount of PtdCho in the CCT  -null cells 
was suffi cient for SM production despite the reduced rate of 
PtdCho synthesis. 
 Both CDP – Cho and DAG are substrates for the CPT that 
makes PtdCho. Limitation of the CDP – Cho supply by genetic 
inactivation of the CCT  accounted for the reduced PtdCho and 
for the metabolic accumulation of DAG after LPS. Affymetrix 
microarray data, available at the National Center for Biotechnology 
Information website (Gene Expression Omnibus; http://www
.ncbi.nlm.nih.gov/;  Shell et al., 2005 ), revealed that expression 
of a select group of lipid metabolic genes increased 18 h after 
LPS stimulation of wild-type macrophages, including those 
encoding the PLD1, the CCT  , and the choline/ethanolamine 
phosphotransferase (C/EPT; Table S1, available at http://www
 Figure 7.  Amounts of PtdCho, DAG, and SM after LPS stimulation. Wild-
type (WT; white) and CCT  -deﬁ cient (KO; black) macrophages were 
incubated with 10 ng/ml LPS or without LPS for 18 h, and total lipids were 
extracted. The identiﬁ cation of PtdCho (A) and SM (C) was determined by 
TLC and comigration with authentic standards, and the amount of each 
lipid was quantiﬁ ed by ﬂ ame ionization using the Iatroscan calibrated with 
known amounts of each standard. The amount of DAG (B) was determined 
by the DAG kinase assay. Values were normalized to cell numbers. Data 
are the mean of determinations from at least two individual mice of each 
genotype. Error bars indicate mean  ± SE. ns, not signiﬁ cant; *, P  < 0.05. 
 Figure 8.  Cycle of PtdCho degradation and resynthesis associated with 
secretion from the Golgi apparatus. PtdCho is degraded by a PLD1 to 
PtdOH, which in turn is converted to DAG by a PtdOH P ’ tse during secretion 
from the trans-Golgi compartment. The C/EPT utilizes DAG and CDP – Cho 
to form PtdCho and replenish the Golgi-associated PtdCho pool. 
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inhibition by 1-butanol ( Fig. 9 B ). Taken together, these data 
 support the idea that de novo PtdCho synthesis was required to 
maintain cytokine secretion from the Golgi apparatus in LPS-
stimulated macrophages. 
 DAG levels were increased to test whether impaired secre-
tion would be the result. At 3 h after LPS stimulation, wild-type 
cells were incubated with increasing concentrations of a phos-
pholipase C isolated from  Bacillus cereus. The phospholipase C 
in the medium converted surface membrane PtdCho to DAG. 
We reasoned that at least a portion of the DAG would relocate 
 intracellularly to the Golgi apparatus, similar to the supplemental 
lysoPC in the medium that resulted in rescue of the phenotype 
( Fig. 9 ). At 6 and 18 h after addition of the enzyme, the amount 
of TNF  in the medium and the amount of DAG in the cells was 
quantifi ed ( Fig. 10 ). Despite substantial increases in DAG that 
correlated with the amount of phospholipase C added ( Fig. 10 A ), 
TNF  secretion was not impaired ( Fig. 10 B ). These data argued 
that increased DAG was not the critical biochemical factor lead-
ing to the knockout phenotype. Rather, depletion of the PtdCho 
supply impeded vesicular transport, resulting in accumulation of 
cytokines in the Golgi apparatus. 
 Discussion 
 Our interpretation of the inhibition of induced cytokine secre-
tion from the knockout cells is that the PtdCho requirement for 
cytokine traffi cking arises from the inability to supply PtdCho 
These results confi rmed that the cellular defect was caused by re-
duced PtdCho synthesis and did not extend to an imbalance in SM 
synthesis ( Fig. 9 B ). SM synthesis and TNF  and IL-6 release to 
the medium were measured in the same experiment in the pres-
ence and absence of fumonesin B1 in wild-type cells. Although 
SM synthesis was severely reduced, the amount of either cytokine 
in the medium was the same with or without inhibitor treatment 
(Fig. S5, C and D). Nor did 2-butanol have an effect, which was 
a treatment control for the specifi city of the phospholipase D 
 Figure 9.  Response of TNF  secretion to different treatments. (A) Wild-
type (WT; white bars) or CCT  -deﬁ cient (KO; black bars) macrophages 
were treated with 10 ng/ml LPS for 18 h. At the same time, 100  μ M 
LysoPC, 15  μ M edelfosine, or solvent vehicle (0.1% ethanol) were added 
to the medium as indicated. The amount of TNF  secreted into the cul-
ture medium was determined using a Quantikine kit, and results are the 
mean values normalized to cellular protein ( n = 8) obtained from four 
mice of each genotype. (B) Wild-type cells were treated with 10 ng/ml 
LPS alone, with LPS plus 10  μ M fumonisin B1 to inhibit ceramide synthesis, 
with LPS plus 50  μ M propranolol to inhibit the PtdOH P ’ tse, with LPS plus 
15 mM 1-butanol to inhibit the phospholipase D, and with LPS plus 20 mM 
2-butanol as an alcohol control for 8 h. Data are the mean of determi-
nations from four individual mice of each genotype. Error bars indicate 
mean  ± SE. *, P  < 0.05. 
 Figure 10.  Cell-associated DAG and TNF  release to the medium after LPS 
and exogenous phospholipase C. Wild-type macrophages were treated 
with LPS for 3 h, then  B. cereus phospholipase C was added at the indi-
cated concentrations for the remainder of the 6- and 18-h incubations. 
(A) Cells were harvested for lipid extraction, and the amount of DAG was 
determined by the DAG kinase assay as described in Materials and methods. 
The values were normalized to cell numbers. (B) TNF  was quantiﬁ ed in 
the medium using the ELISA method. The values were normalized to cell 
number. The data are the mean of values obtained using cells from three 
mice. Error bars indicate mean  ± SE. 
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with the membrane curvature elastic stress that is induced by 
 accumulation of conically shaped membrane lipids ( Attard et al., 
2000 ). The binding of CCT  to membranes increases CDP – Cho 
production at the site of DAG formation to promote PtdCho syn-
thesis by the Golgi-resident CPT or C/EPT enzymes ( Henneberry 
et al., 2001 ). The association of the C/EPT isoform with the 
secretory compartment is suggested by its increased expression 
after LPS stimulation (Fig. S5 E and Table S1). Overexpression 
studies placed the CPT isoform at the Golgi apparatus and the 
C/EPT isoform with the ER ( Henneberry et al., 2002 ). However, 
a later proteomics analysis of the endogenous components of the 
secretory pathway identifed C/EPT rather than CPT in the Golgi 
cisternae ( Gilchrist et al., 2006 ). In addition, increased expression 
of CPT is associated with ER biogenesis in B cells ( Fagone et al., 
2007 ) and fi broblasts ( Sriburi et al., 2004 ). Thus, our data (Fig. S5 E) 
suggest that the C/EPT is the likely participant in PtdCho synthe-
sis associated with secretion from the Golgi apparatus. 
 Our fi ndings in macrophages extend the relationship be-
tween PtdCho synthesis and vesicular traffi cking uncovered in 
lower organisms. Recent studies in  Drosophila melanogaster eye 
development indicate a role for CCT in regulation of the endo-
cytic pathway that results in an altered subcellular localization 
of the EGF and Notch receptors ( Weber et al., 2003 ). Similarly, 
the defects in ovarian development in  D. melanogaster Cct1 mu-
tants are explained by defects in the secretion of signaling mole-
cules through the Golgi apparatus ( Gupta and Sch ü pbach, 2003 ). 
The relationship between Golgi function and PtdCho synthesis 
is most clearly revealed in the yeast system, where the arrest 
of Golgi-mediated secretion by mutations in  sec14 , a PtdCho/
phosphatidylinositol transfer protein, is overcome by mutations 
in the CDP – Cho pathway ( Cleves et al., 1991 ;  Huijbregts et al., 
2000 ). Yeast synthesize the majority of their PtdCho through an 
alternate pathway; thus, inactivation of the CDP – Cho pathway is 
not lethal in that system. The importance of DAG production to 
mammalian Golgi function is also highlighted by the recent work 
with the Nir2 protein. Depletion of the Nir2 protein limits the 
production of DAG in the Golgi, inhibits protein transport from 
the trans-Golgi to the plasma membrane, and affects the structural 
integrity of the Golgi apparatus ( Litvak et al., 2005 ). There is a 
distinct difference in CCT  localization, and perhaps its metabolic 
role, in transformed cultured cells compared with primary cells. 
Although CCT  is located in association with the Golgi complex 
and outside the nucleus in primary macrophages ( Fig. 6 ), it is 
found predominantly within the nucleus of transformed macro-
phages and HeLa cells ( Lykidis et al., 1999 ). In all of the pri-
mary cells examined thus far, including macrophages (this paper), 
lung secretory type II cells ( Ridsdale and Post, 2004 ), and B lym-
phocytes ( Fagone et al., 2007 ), the CCT  is located outside the 
nucleus and often in association with organellar membranes. 
 Materials and methods 
 CCT  -deﬁ cient macrophages 
 Homozygous  Pcyt1a ﬂ ox mice ( Zhang et al., 2000 ) were obtained from 
I. Tabas (Columbia University, New York, NY) and bred with LysMCre mice 
(obtained from I. F ö rster, Technical University of Munich, Munich, Germany; 
courtesy of P. Murray, St. Jude Children ’ s Research Hospital, Memphis, TN) 
as described previously ( Clausen et al., 1999 ;  Zhang et al., 2000 ) to obtain 
to the Golgi apparatus. The PtdCho degradation mediated 
by phospholipase D that accompanies cytokine secretion in 
LPS-stimulated cells depletes PtdCho in the absence of CCT  -
dependent de novo synthesis, resulting in a lipid imbalance 
exemplifi ed by an increase in DAG. The activities and Golgi lo-
calizations of both CCT  and the C/EPT in wild-type cells en-
able rapid resupply of PtdCho. The residual CCT activity in the 
knockout cells, caused by CCT  3 expression, is not suffi cient 
or not located in the appropriate cellular compartment (Fig. S4 D) 
to provide the PtdCho necessary to support cytokine secretion. 
Two datasets support this interpretation: the lower rate of 
PtdCho synthesis in the knockout cells compared with the wild 
type ( Figs. 1 A and S5 A) and the lower amount of PtdCho per 
cell in the CCT  knockouts after LPS stimulation ( Fig. 7 A ). 
In contrast, ApoE secretion is not dependent on de novo PtdCho 
synthesis ( Figs. 3 D and S3). The data indicate that ApoE pro-
tein exits the Golgi compartment by a pathway distinct from the 
TNF  and IL-6 cytokines. ApoE is concentrated in a subclass of 
Golgi-derived vesicles distinct from those vesicles that contain 
secretory albumin ( Gusarova et al., 2007 ). ApoE secretion is 
linked to cellular sphingolipid synthesis ( Lucic et al., 2007 ), 
and neither process is impaired in the CCT  knockout macro-
phages ( Figs. 7 C and S5 B). 
 CCT  participates in a cycle of PtdCho degradation and re-
synthesis illustrated in  Fig. 8 . The ER is a major cellular site for 
membrane biogenesis ( Fagone et al., 2007 ;  Sriburi et al., 2007 ), 
and new phospholipid is distributed throughout the cell via mem-
brane lateral diffusion, vesicular transport, or protein carriers to 
other membrane-delimited organelles ( Trotter and Voelker, 1994 ). 
The replenishment of PtdCho and the removal of DAG in the 
Golgi can occur via these transport processes. However, our ex-
periments suggest that CCT  expression (Fig. S5 E and Table S1) 
and association with the trans-Golgi compartment ( Fig. 6 ) are 
required to provide new CDP – Cho that is used by the Golgi-
localized C/EPT (Fig. S5 E and Table S1) to resupply PtdCho. 
The heightened activity of phospholipase D ( Bi et al., 1997 ; 
 Corda et al., 2002 ;  Freyberg et al., 2003 ;  Jenkins and Frohman, 
2005 ) during LPS-stimulated cytokine secretion degrades the 
Golgi-associated PtdCho and yields DAG. A threshold level of 
DAG is required for secretion in yeast ( Kearns et al., 1997 ) and 
HeLa cells ( Litvak et al., 2005 ;  Lev, 2006 ). The DAG recruits 
specifi c proteins to the Golgi apparatus that function in vesicu-
lar transport ( Patton-Vogt et al., 1997 ;  Roth, 1999 ;  Baron and 
Malhotra, 2002 ;  Corda et al., 2002 ) and induces curvature in the 
phospholipid bilayer that is postulated to promote membrane fusion 
and fi ssion events ( Shemesh et al., 2003 ). However, our results 
 indicate that aberrantly high DAG does not impede vesicular trans-
port from the Golgi complex ( Fig. 10, A and B ; and Fig. S5 F). 
 The association of CCT  with the trans-Golgi compart-
ment during TNF  secretion ( Fig. 6 ) is consistent with its ability 
to translocate to membranes enriched in DAG and become acti-
vated. CCT  reversibly binds to biological membranes via its 
amphipathic   -helical domain, and DAG is among the most potent 
membrane components that promote CCT  binding in vitro and 
in vivo ( Kent, 1997 ;  Cornell and Northwood, 2000 ;  Jackowski 
and Fagone, 2005 ;  Cornell and Taneva, 2006 ). CCT  mem-
brane association is not specifi c for DAG but rather correlates 
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cultured cells were washed three times with ice-cold PBS and lysed in 20 mM 
Tris-HCl, pH 7.5, containing 150 mM NaCl, 2 mM EDTA, 1% Triton X-100, 
10 Mg/ml leupeptin, 10 Mg/ml pepstatin, 1 mM PMSF, and a cocktail of 
serine/threonine P ’ tse inhibitors. In other experiments, edelfosine (EMD), 
lysoPC (Sigma-Aldrich), fumonisin B1 (Sigma-Aldrich), 1-butanol (Sigma-
Aldrich), 2-butanol (Sigma-Aldrich), and propranolol (EMD) were added at 
the concentrations indicated. 
 Immunoblotting 
 Cells were stimulated with LPS for the indicated times, washed twice with 
ice-cold PBS before scraping, and lysed with buffer (50 mM Tris/HCl, 
pH 7.5, 150 mM NaCl, 1% Triton X-100, 1% deoxycholate, 1 mM EGTA, 
0.4 mM EDTA, 2.5  μ g/ml aprotinin, 2.5  μ g/ml leupeptin, 1 mM phenyl-
methanesulfonyl ﬂ uoride, and 0.2 mM Na 3 VO 4 ). Where indicated, 20  μ M 
TAPI (EMD), an inhibitor of TACE, was added together with LPS. Equal 
amounts of protein lysates were resolved by SDS-PAGE and transferred to 
polyvinylidene diﬂ uoride membranes. Blots were blocked in 5% nonfat dry 
milk in TBST buffer (20 mM Tris-HCl, 0.15 M NaCl, and 0.1% Tween-20) 
and immunoblotted with anti-TNF  antibody (Abcam or Cayman Chemical). 
Signal was detected using a secondary antibody conjugated to horseradish 
peroxidase and incubation for 2 min with ECL reagent (GE Healthcare) 
 according to the manufacturer ’ s instructions. Blots were exposed to Hyper-
ﬁ lm ECL (GE Healthcare) and developed. 
 Immunocytochemistry 
 Cells were seeded at a density of 2.5  × 10 4 cells per well on poly-lysine –
 coated coverslips in 24-well plates and cultured. After treatment with 
10 ng/ml LPS, cells were washed twice with cold PBS and ﬁ xed in 4% 
paraformaldehyde in 0.1 M phosphate buffer, pH 7.4, for 10 min at 25 ° C. 
After two 5 min washes with PBS, pH 7.6, cells were permeabilized and 
blocked by blocking buffer containing 0.2% Triton X-100 and 1.5% horse 
serum in PBS. Cells were then incubated overnight at 4 ° C with FITC-labeled 
anti – mouse CD11b (GE Healthcare), anti-TNF  (Abcam), anti-CCT  (Santa 
Cruz Biotechnology, Inc.), anti – ERGIC-53 (Sigma-Aldrich), anti-K58 (Abcam), 
anti – MAC-1 (Abcam), or anti – IL-6 (Abcam). The next morning, the primary 
antibodies were washed three times for 5 min with TBS with 0.2% Triton 
X-100, and a 1:200 dilution in blocking buffer of Alexa 488 – or Alexa 594 –
 conjugated secondary anti – rabbit Ig antibody (Invitrogen) was added 
to the cells, which were incubated for 1 h at 25 ° C. After three ﬁ nal 5-min 
washes with PBS, cells were mounted in mounting medium with DAPI (Invit-
rogen). Fluorescence microscopy was performed by the Scientiﬁ c Imaging 
Shared Resource at St. Jude Children ’ s Research Hospital using a micro-
scope (E800; Nikon) equipped with 40 × 0.95 NA and 20 × 0.50 NA ob-
jectives (Nikon). The images were obtained using ProLong Gold Antifade 
Reagent (with DAPI; Invitrogen) and ﬂ uorochromes Alexa 594 and 488 
(Invitrogen). The images were recorded with a camera (DMX1200; Nikon) 
and ACT acquisition software (Nikon) and prepared for publication using 
Photoshop CS2 (Adobe) for picture size and solution adjustment. 
 Real-time qRT-PCR 
 Real-time qRT-PCR was used to determine the relative expression levels of 
the  Pcyt1a ,  Pld1 , and  Cept1 genes in wild-type macrophages. Total RNA 
was isolated using the RNAeasy Mini kit (QIAGEN) according to the 
manufacturer ’ s instructions. Pelleted RNA was resuspended in nuclease-free 
water and digested with DNase I to remove contaminating genomic DNA. 
Total RNA (0.5  μ g) was reverse transcribed using random primers and 
SuperScript II RNase H    reverse transcription (Invitrogen). Real-time qPCR 
was performed with 10% of the reverse transcription product in a 30- μ l 
reaction volume of Taqman Universal PCR master mixes (Applied Bio-
systems) using the 7300 sequence detection system and software version 
1.2.1 (Applied Biosystems). Speciﬁ c primers and probes are listed in Table S2 
(available at http://www.jcb.org/cgi/content/full/jcb.200706152/DC1). 
The Taqman rodent glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 
control reagent (Applied Biosystems) was the source of the primers and 
probes for quantifying the control GAPDH mRNA. All of the real-time val-
ues were averaged and compared using the  C T method, where the amount 
of target RNA (2 -    CT ) was normalized to the endogenous GAPDH refer-
ence (  C T ) and related to the amount of target transcript in untreated con-
trol cells (   C T ), which was set as the calibrator at 1.0. 
 Mouse infection model 
 Strain T4X of  S. pneumoniae , a type 4 encapsulated, stable, biolumines-
cent derivative of clinical strain TIGR4, was grown as described previously 
( Orihuela et al., 2004 ). Wild-type and knock out mice were anesthetized 
with 2.5% isoﬂ urane (Baxter Healthcare Corp) and infected intranasally 
with 10 7 colony-forming units per 25  μ l of  S. pneumoniae T4X. Mice were 
knockout and littermate wild-type macrophages. The two ﬂ ox sites ﬂ anked a 
12.5-kb fragment of the gene containing exons 5 – 9 (renumbered;  Karim 
et al., 2003 ), the intervening introns, and parts of introns 4 and 9. Deletion 
of the region between the ﬂ ox sites resulted in loss of the catalytic domain of 
the CCT  protein. The resulting transcript encoded a truncated protein that 
lacked the catalytic domain and the regulatory domains located at the car-
boxy terminus. The  Neo cassette and a third ﬂ ox site that were origi-
nally inserted into the gene and used for embryonic stem cell selection of 
recombinants was removed by mating with an EIIa Cre mouse (The Jackson 
Laboratory) to avoid hypomorphic effects on CCT  expression in the un-
deleted macrophages from littermates ( Zhang et al., 2000 ). Genotyping of 
tails and macrophages was performed as described previously ( Zhang et al., 
2000 ). Macrophages were elicited by injection of 3 ml thioglycolate 
(Becton Dickinson) followed by peritoneal lavage with PBS containing 5 U/ml 
heparin. After hypertonic lysis of the erythrocytes using 10 mM KHCO 3 , 
150 mM NH 4 Cl, and 0.1 mM Na 2 EDTA, pH 7.65, macrophages were cul-
tured in L cell – conditioned medium (LCM) as described previously ( Tang et al., 
1999 ). LPS from  E. coli (Sigma-Aldrich) was dissolved in PBS, and optimized 
concentrations were 10 or 100 ng/ml and lot number – dependent. 
 CCT activity and expression 
 CCT activities in macrophage cell lysates were determined essentially as 
described previously ( Luche et al., 1993 ). Protein concentration was de-
termined according to the Bradford method using   -globulin as a stan-
dard ( Bradford, 1976 ). Total RNA was isolated from cells using TRIzol 
reagent (Invitrogen) as described previously ( Wang et al., 2005 ). Real-
time PCR was used to determine the relative expression levels of the 
CCT  , CCT  2, CCT  3, and phosphatidylethanolamine methyltransfer-
ase (PEMT) isoform transcripts encoded by the  Pcyt1a , Pcyt1b , and  Pemt 
genes as described previously ( Jackowski et al., 2004 ). Immunoblotting 
with CCT isoform-speciﬁ c antibodies has been described previously ( Lykidis 
et al., 2001 ). 
 Lipid analysis 
 2.5  × 10 5 macrophages were plated in 60-mm dishes and incubated over-
night in LCM. For radiolabeling experiments, adherent cells were incu-
bated in fresh LCM containing either 1  μ Ci/ml [methyl- 3 H]choline chloride 
or 10  μ Ci/ml [ 3 H]palmitic acid (American Radiolabeled Chemicals, Inc.)  ± 
10 ng/ml LPS for the time indicated in the ﬁ gure legends. Lipids were ex-
tracted as described previously ( Bligh and Dyer, 1959 ) and fractionated 
on preadsorbent H silica thin-layer plates (Analtech) developed with 
 chloroform/methanol/acetic acid (98:2:1) or chloroform/methanol/ 
ammonium hydroxide (60:35:8). Areas corresponding to PtdCho, PtdEtn, 
and SM standards were counted. For measurements of lipid quantity, ex-
tracted lipid mixtures were fractionated on silica gel rods using the same 
solvent systems, and the amount of each identiﬁ ed lipid was quantiﬁ ed by 
ﬂ ame ionization using an Iatroscan (Iatron Instruments). DAG was quanti-
ﬁ ed in lipids extracted from cells as described previously ( Preiss et al., 1987 ) 
and normalized to cell number. Protein was quantiﬁ ed by the Bradford 
method ( Bradford, 1976 ). 
 Phagocytosis assays 
 Macrophages were plated at a density of 10 5 per well in 96-well black 
plates (Corning) and cultured overnight in LCM. A bacterial suspension con-
taining   1  × 10 8 ﬂ uorescent bacteria from the Vybrant phagocytosis assay 
kit (Invitrogen) was added and incubated for 2 or 4 h at 37 ° C. Quantiﬁ ca-
tion was performed according to the manufacturer ’ s instructions on a Fusion 
Universal Microplate Analyzer plate reader (PerkinElmer). 10  μ g/ml DAPI 
(Invitrogen) was added to determine cell numbers. 
 Chemotaxis assays 
 Cell migration assays were performed in 96-well MultiScreen-MIC plates 
(Millipore) with 5-mm-pore-sized polycarbonate membrane. 10 nM fMLP 
(EMD) was or was not added to the lower wells. Cells that migrated after 
4 h were stained with Calcein AM quantiﬁ ed using a Fusion Universal 
Microplate Analyzer plate reader. 
 Cytokine and prostaglandin assays 
 Macrophages were cultured with LCM containing 10 – 100 ng/ml LPS, and, 
as indicated, 200  μ l aliquots of culture medium were removed and assayed 
for TNF  , IL-6, IL-1  , or PGE 2 content by ELISA (Quantikine R & D Systems; 
Cayman Chemical) according to the manufacturer ’ s instructions. The anti-
body used in the TNF  ELISA recognized both the precursor pro-TNF  and 
the mature TNF  isoforms. Where indicated, cells were harvested and 
lysates were prepared as described previously ( Mbebi et al., 2005 ). In brief, 
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